DigestRedComo funciona
Red
/
Empresas
BP
No verificado

BPGbio, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosOncologíaSalud

19 Comunicados de prensa

Ver todos los comunicados de prensa
20/03/2025
Eventos
Industria
Técnica
Ciencia
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Oncología
BPGbio to Present Novel E2-based Targeted Protein Degradation Program at 5th Annual TPD and Induced Proximity Summit in Europe
Fuente
BPGbio, Inc.
Editor
Business Wire
1.00
0
22/01/2025
Industria
Eventos
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
BPGbio Unveils Research on the Identification of Novel Pancreatic Cancer Patient Subtypes at ASCO GI 2025 Paving the Way for Tailored Treatment
Fuente
BPGbio, Inc.
Editor
Business Wire
1.00
0
21/11/2024
Ciencia
Técnica
Medicina - Varios
Biotecnología
Farmacéutica
Salud
Oncología
Eventos
Industria
BPGbio to Present New Data on Novel Glioblastoma Therapies at SNO 2024
Fuente
BPGbio, Inc.
Editor
Business Wire
1.00
0
07/11/2024
Eventos
Biotecnología
Farmacéutica
Oncología
Salud
Técnica
Medicina - Varios
BPGbio to Present Transformative Immuno-Oncology Research on BPM31510 and BRG399 at SITC 2024
Fuente
BPGbio, Inc.
Editor
Business Wire
1.00
0
31/10/2024
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Higiene alimentaria
Medicina - Varios
CORRECTING and REPLACING BPGbio Receives FDA Rare Pediatric Disease Designation for its Investigational Treatment for Epidermolysis Bullosa
Fuente
BPGbio, Inc.
Editor
Business Wire
1.00
0
31/10/2024
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Higiene alimentaria
Medicina - Varios
BPGbio Receives FDA Rare Pediatric Disease Designation for its Investigational Treatment for Epidermolysis Bullosa
Fuente
BPGbio, Inc.
Editor
Business Wire
1.00
0
28/10/2024
Eventos
Software
Ciencia
Farmacéutica
Oncología
Técnica
Medicina - Varios
Biotecnología
Salud
BPGbio CEO Niven R. Narain to Present at Google’s Inaugural Cancer AI Symposium
Fuente
BPGbio, Inc.
Editor
Business Wire
1.00
0
24/10/2024
Eventos
Industria
Software
Biotecnología
Farmacéutica
Salud
Técnica
Medicina - Varios
BPGbio to Present Novel E2-based Targeted Protein Degradation Program at TPD and Induced Proximity Summit
Fuente
BPGbio, Inc.
Editor
Business Wire
1.00
0
23/10/2024
Eventos
Industria
Biotecnología
Técnica
Salud
Farmacéutica
Oncología
Ciencia
Medicina - Varios
BPGbio to Present New Data on BPM31510 and Novel Quinomics Technology for Treatment of Primary CoQ10 Deficiency at MitoCon 2024
Fuente
BPGbio, Inc.
Editor
Business Wire
1.00
0
15/10/2024
Eventos
Ferias y Congresos
Industria
Técnica
Biotecnología
Salud
Farmacéutica
Oncología
Ciencia
Software
Sanidad
Medicina - Varios
BPGbio to Present on E2-based Approach to Targeted Protein Degradation at US Pharma Partnering Summit
Fuente
BPGbio, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0